45 CFR § 180 compliance
F · 50
This hospital published little of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
○Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
4,688
Insurances with rates
0
CPT / HCPCS codes
830
Source MRF
Most expensive procedures (gross)
60006591387
—
nusinersen 2.4mg/mL 5mL vial (G/K)
Gross
$168,770
60006591191
—
histrelin (Supprelin LA) 50mg subcut implant (G/K)
Gross
$71,244
60006549968
—
carmustine 7.7mg wafer (pkg of 8)
Gross
$58,074
60006592021
—
glucarpidase 1000 Unit(s) vial
Gross
$44,342
60006582423
—
ipilimumab 5mg/mL 40mL vial (G/K)
Gross
$36,217
60006585426
—
sipuleucel-T 50million CD54+ cells in 250mL LR (G/K)
Gross
$33,364
60006590948
—
alemtuzumab 10mg/mL 1.2mL soln (G/K)
Gross
$30,541
60006591847
—
pegloticase 8mg/mL 1mL vial (G/K)
Gross
$28,613
60006591924
—
inotuzumab ozogamicin 0.9mg vial (G/K)
Gross
$27,016
60006591374
—
ocrelizumab 30mg/mL 10mL vial (G/K)
Gross
$22,770
60006591992
—
polatuzumab vedotin 140mg vial (G/K)
Gross
$21,020
60006555072
—
pegaspargase 750 Unit(s)/mL 5mL vial (G/K)
Gross
$18,905
60006591976
—
tildrakizumab-asmn (Ilumya) 100 mg/mL syringe (G/K)
Gross
$18,579
60006581920
—
coagulation factor VIIa 8000 mcg (8 mg) Inject (G/K)
Gross
$18,530
60006591038
—
vinCRIStine liposome 5 mg/31mL (G/K)
Gross
$15,958
60006591548
—
PRALAtrexate 20mg/mL 2mL soln (G/K)
Gross
$15,290
60006575906
—
cabazitaxel 60mg (G/K)
Gross
$15,050
60006591386
—
immune globulin (Privigen) 40gm/400mL premix (G/K)
Gross
$14,195
60006583124
—
coagulation factor VIIa 5000 mcg (5 mg) Inject (G/K)
Gross
$13,883
60006591785
—
cemiplimab-rwlc 50 mg/mL 7mL soln (G/K)
Gross
$13,670
60006591218
—
atezolizumab 60mg/mL 20mL soln (G/K)
Gross
$13,541
60006591268
—
natalizumab 300mg/115mL NS IVPB (G/K)
Gross
$13,271
60006591977
—
leuprolide 30 mg/3 months kit (PED) (G/K)
Gross
$12,961
60006591647
—
gemtuzumab ozogamicin 4.5mg vial (G/K)
Gross
$12,350
60006538680
—
alteplase 100mg vial (G/K)
Gross
$12,019
60006590533
—
lanreotide 120mg/0.5mL inj (G/K)
Gross
$11,971
60006591610
—
daunorubicin/cytarabine liposomal 44 mg-100 mg inj (G/K)
Gross
$11,675
60006591737
—
hyaluronidase-rituximab 26,800units-1600mg/13.4mL vial (G/K)
Gross
$11,295
60006591223
—
brentuximab vedotin 50mg vial (G/K)
Gross
$11,113
60006591820
—
leuprolide 11.25 mg/3 months kit (PED) (G/K)
Gross
$11,096
60006564462
—
hemin 313mg vial (G/K)
Gross
$10,868
60006591452
—
hemin 350mg vial (G/K)
Gross
$10,868
60006581953
—
ipilimumab 5mg/mL 10mL vial (G/K)
Gross
$10,781
60006590673
—
plerixafor 20mg/mL 1.2mL vial (G/K)
Gross
$10,676
60006591724
—
immune globulin (Gammagard) 30gm/300mL premix (G/K)
Gross
$10,309
60006563274
—
thalidomide 50mg capsule pkg of 28
Gross
$10,231
60006591236
—
lanreotide 90mg/0.3mL inj (G/K)
Gross
$10,154
60006591736
—
hyaluronidase-rituximab 23,400units-1400mg/11.7mL vial (G/K)
Gross
$9,885
60006590897
—
obinutuzumab 25mg/mL 40mL soln (G/K)
Gross
$9,702
60006591395
—
eculizumab 10mg/mL 30mL vial (G/K)
Gross
$9,641
60006591985
—
atezolizumab 60mg/mL 14mL soln (G/K)
Gross
$9,485
60006591686
—
nivolumab 10mg/mL 24mL soln (G/K)
Gross
$9,460
60006563951
—
natalizumab 20mg/mL 15mL vial (G/K)
Gross
$9,290
60006585228
—
agalsidase beta 35mg inj (G/K)
Gross
$9,125
60006577530
—
octreotide LAR 30mg depot kit (G/K)
Gross
$8,827
60006590806
—
vedolizumab 300mg vial (G/K)
Gross
$8,815
60006592009
—
lanreotide 60 mg/0.2mL inj (G/K)
Gross
$8,800
60006585657
—
pertuzumab 420mg/14mL soln (G/K)
Gross
$8,800
60006591547
—
PRALAtrexate 20mg/mL 1mL soln (G/K)
Gross
$8,800
60006590955
—
ramucirumab 10mg/mL 50mL vial (G/K)
Gross
$8,800
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 60006591387 | nusinersen 2.4mg/mL 5mL vial (G/K) | $168,770 | — | — | — | 0 |
| 60006591191 | histrelin (Supprelin LA) 50mg subcut implant (G/K) | $71,244 | — | — | — | 0 |
| 60006549968 | carmustine 7.7mg wafer (pkg of 8) | $58,074 | — | — | — | 0 |
| 60006592021 | glucarpidase 1000 Unit(s) vial | $44,342 | — | — | — | 0 |
| 60006582423 | ipilimumab 5mg/mL 40mL vial (G/K) | $36,217 | — | — | — | 0 |
| 60006585426 | sipuleucel-T 50million CD54+ cells in 250mL LR (G/K) | $33,364 | — | — | — | 0 |
| 60006590948 | alemtuzumab 10mg/mL 1.2mL soln (G/K) | $30,541 | — | — | — | 0 |
| 60006591847 | pegloticase 8mg/mL 1mL vial (G/K) | $28,613 | — | — | — | 0 |
| 60006591924 | inotuzumab ozogamicin 0.9mg vial (G/K) | $27,016 | — | — | — | 0 |
| 60006591374 | ocrelizumab 30mg/mL 10mL vial (G/K) | $22,770 | — | — | — | 0 |
| 60006591992 | polatuzumab vedotin 140mg vial (G/K) | $21,020 | — | — | — | 0 |
| 60006555072 | pegaspargase 750 Unit(s)/mL 5mL vial (G/K) | $18,905 | — | — | — | 0 |
| 60006591976 | tildrakizumab-asmn (Ilumya) 100 mg/mL syringe (G/K) | $18,579 | — | — | — | 0 |
| 60006581920 | coagulation factor VIIa 8000 mcg (8 mg) Inject (G/K) | $18,530 | — | — | — | 0 |
| 60006591038 | vinCRIStine liposome 5 mg/31mL (G/K) | $15,958 | — | — | — | 0 |
| 60006591548 | PRALAtrexate 20mg/mL 2mL soln (G/K) | $15,290 | — | — | — | 0 |
| 60006575906 | cabazitaxel 60mg (G/K) | $15,050 | — | — | — | 0 |
| 60006591386 | immune globulin (Privigen) 40gm/400mL premix (G/K) | $14,195 | — | — | — | 0 |
| 60006583124 | coagulation factor VIIa 5000 mcg (5 mg) Inject (G/K) | $13,883 | — | — | — | 0 |
| 60006591785 | cemiplimab-rwlc 50 mg/mL 7mL soln (G/K) | $13,670 | — | — | — | 0 |
| 60006591218 | atezolizumab 60mg/mL 20mL soln (G/K) | $13,541 | — | — | — | 0 |
| 60006591268 | natalizumab 300mg/115mL NS IVPB (G/K) | $13,271 | — | — | — | 0 |
| 60006591977 | leuprolide 30 mg/3 months kit (PED) (G/K) | $12,961 | — | — | — | 0 |
| 60006591647 | gemtuzumab ozogamicin 4.5mg vial (G/K) | $12,350 | — | — | — | 0 |
| 60006538680 | alteplase 100mg vial (G/K) | $12,019 | — | — | — | 0 |
| 60006590533 | lanreotide 120mg/0.5mL inj (G/K) | $11,971 | — | — | — | 0 |
| 60006591610 | daunorubicin/cytarabine liposomal 44 mg-100 mg inj (G/K) | $11,675 | — | — | — | 0 |
| 60006591737 | hyaluronidase-rituximab 26,800units-1600mg/13.4mL vial (G/K) | $11,295 | — | — | — | 0 |
| 60006591223 | brentuximab vedotin 50mg vial (G/K) | $11,113 | — | — | — | 0 |
| 60006591820 | leuprolide 11.25 mg/3 months kit (PED) (G/K) | $11,096 | — | — | — | 0 |
| 60006564462 | hemin 313mg vial (G/K) | $10,868 | — | — | — | 0 |
| 60006591452 | hemin 350mg vial (G/K) | $10,868 | — | — | — | 0 |
| 60006581953 | ipilimumab 5mg/mL 10mL vial (G/K) | $10,781 | — | — | — | 0 |
| 60006590673 | plerixafor 20mg/mL 1.2mL vial (G/K) | $10,676 | — | — | — | 0 |
| 60006591724 | immune globulin (Gammagard) 30gm/300mL premix (G/K) | $10,309 | — | — | — | 0 |
| 60006563274 | thalidomide 50mg capsule pkg of 28 | $10,231 | — | — | — | 0 |
| 60006591236 | lanreotide 90mg/0.3mL inj (G/K) | $10,154 | — | — | — | 0 |
| 60006591736 | hyaluronidase-rituximab 23,400units-1400mg/11.7mL vial (G/K) | $9,885 | — | — | — | 0 |
| 60006590897 | obinutuzumab 25mg/mL 40mL soln (G/K) | $9,702 | — | — | — | 0 |
| 60006591395 | eculizumab 10mg/mL 30mL vial (G/K) | $9,641 | — | — | — | 0 |
| 60006591985 | atezolizumab 60mg/mL 14mL soln (G/K) | $9,485 | — | — | — | 0 |
| 60006591686 | nivolumab 10mg/mL 24mL soln (G/K) | $9,460 | — | — | — | 0 |
| 60006563951 | natalizumab 20mg/mL 15mL vial (G/K) | $9,290 | — | — | — | 0 |
| 60006585228 | agalsidase beta 35mg inj (G/K) | $9,125 | — | — | — | 0 |
| 60006577530 | octreotide LAR 30mg depot kit (G/K) | $8,827 | — | — | — | 0 |
| 60006590806 | vedolizumab 300mg vial (G/K) | $8,815 | — | — | — | 0 |
| 60006592009 | lanreotide 60 mg/0.2mL inj (G/K) | $8,800 | — | — | — | 0 |
| 60006585657 | pertuzumab 420mg/14mL soln (G/K) | $8,800 | — | — | — | 0 |
| 60006591547 | PRALAtrexate 20mg/mL 1mL soln (G/K) | $8,800 | — | — | — | 0 |
| 60006590955 | ramucirumab 10mg/mL 50mL vial (G/K) | $8,800 | — | — | — | 0 |
Showing top 50 of 4,688 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.